Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 26.90% vs 32.72% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 103.86% vs 6.92% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 19.62% vs 17.92% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 160.87% vs 552.66% in Mar 2024
Compare Profit and Loss Results of Niva Bupa Health
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
5,324.00
15,594.00
-10,270.00
-65.86%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
5,324.00
15,594.00
-10,270.00
-65.86%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
663.00
1,692.00
-1,029.00
-60.82%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
0.00
0.00
0.00
0%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
-62.00
-62.00
0.00
0.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
5,163.00
15,049.00
-9,886.00
-65.69%
Operating Profit (PBDIT) excl Other Income
160.00
544.00
-384.00
-70.59%
Other Income
205.00
518.00
-313.00
-60.42%
Operating Profit (PBDIT)
366.00
1,063.00
-697.00
-65.57%
Interest
127.00
130.00
-3.00
-2.31%
Profit before Depriciation and Tax
238.00
933.00
-695.00
-74.49%
Depreciation
24.00
71.00
-47.00
-66.20%
Profit Before Taxation & Exceptional Items
214.00
861.00
-647.00
-75.15%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
213.00
861.00
-648.00
-75.26%
Provision for Tax
0.00
215.00
-215.00
-100.00%
Profit After Tax
213.00
645.00
-432.00
-66.98%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
-286.00
286.00
100.00%
Profit Available for appropriations
213.00
359.00
-146.00
-40.67%
Appropriations
213.00
359.00
-146.00
-40.67%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.22
11.01
-9.79
-88.92%
Profit And Loss - Net Sales
Net Sales 5,324.26 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 26.90% vs 32.72% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 160.64 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 103.86% vs 6.92% in Mar 2024
Profit And Loss - Interest
Interest 127.32 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 19.62% vs 17.92% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 213.52 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 160.87% vs 552.66% in Mar 2024






